Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interleukin-2 in Metastatic Melanoma
NCT00002845Phase 2Unknown
- Sponsor
- Levine Cancer Institute
- Start
- Sep 1995
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in melanoma, sponsored by Levine Cancer Institute. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00002845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002845.